Nirlac Biotec Private Limited
About Nirlac Biotec Private Limited
Data last updated:
Nirlac Biotec Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 July 1993.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1993PTC073192. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Ranil Pharma Pvt Ltd.
Its last annual general meeting (AGM) was held on 30 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at 14th Floor Nirmal Bldg Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2020, the company reported a revenue of ₹3.59 Lakh, a decline of 92% compared to the previous year. For the same year it recorded a net loss of ₹3.28 Lakh (net margin -91.5%) and EBITDA of -₹3.28 Lakh (EBITDA margin -91.5%). Revenue has declined at a compounded annual rate (CAGR) of 74% over three years and 39% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address14th Floor Nirmal Bldg Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Nirlac Biotec Private Limited FY 2020 filings available
Nirlac Biotec Private Limited reported revenue of ₹3.59 Lakh (down 92% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Nirlac Biotec Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 39% over five years, including a 92% fall in the latest year. EBITDA fell 256% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nirlac Biotec Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹3.59 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.28 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.28 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nirlac Biotec Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -91.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -91.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nirlac Biotec are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nirlac Biotec Private Limited
Nirlac Biotec Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alef Pharmaceuticals Private Limited | ₹3.63 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Lucknow, Uttar Pradesh, India |
| Dermacures3 Private Limited | ₹3.62 Lakh (FY 2018) | •••• | •••• | •••• | Airoli, Maharashtra, India | |
| Syspar India Formulations Private Limited | ₹3.6 Lakh (FY 2025) | •••• | •••• | -33.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Docile Healthcare Private Limited | ₹3.6 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | Rishikesh, Uttarakhand, India |
| Aren Sourcing Private Limited | ₹3.59 Lakh (FY 2020) | •••• | •••• | 479228.0% | •••• | Mumbai, Maharashtra, India |
| Nirlac Biotec Private Limited this company | ₹3.59 Lakh (FY 2020) | •••• | •••• | -92.0% | •••• | Mumbai, Maharashtra, India |
| Womco Laboratories Private Limited | ₹3.58 Lakh (FY 2019) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Nature Proteins Private Limited | ₹3.58 Lakh (FY 2024) | •••• | •••• | 6348.0% | •••• | Chandigarh, India |
| Radics Healthcare Private Limited | ₹3.58 Lakh (FY 2021) | •••• | •••• | -40.0% | •••• | Kolkata, West Bengal, India |
| Truzen Lifesciences Private Limited | ₹3.5 Lakh (FY 2024) | •••• | •••• | 169.0% | •••• | Chennai, Tamil Nadu, India |
| Amazing Research Laboratories Limited | ₹3.48 Lakh (FY 2025) | •••• | •••• | -100.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Nirlac Biotec by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nirlac Biotec Private Limited
Nirlac Biotec Private Limited is audited by JAGDISH BANSAL & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAGDISH BANSAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nirlac Biotec Private Limited
Nirlac Biotec has 5 former directors on record and no current directors listed.
Ownership and Shareholding of Nirlac Biotec Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nirlac Biotec Private Limited
Nirlac Biotec Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nirlac Biotec Private Limited
Employment history and EPFO contributions of people linked to Nirlac Biotec.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nirlac Biotec Private Limited
Nirlac Biotec Private Limited has 5 board changes on record since 2008: 0 appointments and 5 cessations. The latest: Bhavik Nirmal Jain ceased to be Director on 20 Oct 2020.
Credit Ratings, Litigation & Regulatory Alerts for Nirlac Biotec Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nirlac Biotec Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nirlac Biotec Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nirlac Biotec Private Limited
Nirlac Biotec has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nirlac Biotec Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirlac Biotec Private Limited
Nirlac Biotec has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Nirlac Biotec was a private limited company based in Mumbai, Maharashtra, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 July 1993 and is registered under CIN U24239MH1993PTC073192. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Nirlac Biotec is U24239MH1993PTC073192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nirlac Biotec was incorporated on 28 July 1993. It is registered with the Registrar of Companies, Mumbai.
The registered office of Nirlac Biotec is at 14th Floor Nirmal Bldg Nariman Point, Mumbai, Maharashtra, India – 400021.
Nirlac Biotec reported revenue of ₹3.59 Lakh for FY 2020 (down 92% YoY).
Nirlac Biotec has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.
Nirlac Biotec reported a net loss of ₹3.28 Lakh (net margin -91.5%) and EBITDA of -₹3.28 Lakh (EBITDA margin -91.5%) for FY 2020, as per its filed financial statements.
No. Nirlac Biotec has 1 GST registration on record and it is cancelled or inactive.
Nirlac Biotec operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compounded annual growth rate (CAGR) of the revenue of Nirlac Biotec is -74% over three years and -39% over five years. In the latest year (FY 2020) revenue fell 92%. CAGR is the steady yearly rate that links the first and the last year.